Literature DB >> 19710560

Efficacy of darunavir despite low plasma trough levels during late pregnancy in an HIV-hepatitis C virus-infected patient.

Jérôme Pacanowski, Diane Bollens, Jean-Marie Poirier, Laurence Morand-Joubert, Vanina Castaigne, Pierre-Marie Girard, Marie-Caroline Meyohas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19710560     DOI: 10.1097/QAD.0b013e32832e534b

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women.

Authors:  Alice Stek; Brookie M Best; Jiajia Wang; Edmund V Capparelli; Sandra K Burchett; Regis Kreitchmann; Kittipong Rungruengthanakit; Tim R Cressey; Lynne M Mofenson; Elizabeth Smith; David Shapiro; Mark Mirochnick
Journal:  J Acquir Immune Defic Syndr       Date:  2015-09-01       Impact factor: 3.731

2.  Steady-state pharmacokinetics, cord blood concentrations, and safety of ritonavir-boosted fosamprenavir in pregnancy.

Authors:  Michelle S Cespedes; Delivette Castor; Susan L Ford; Doreen Lee; Yu Lou; Gary E Pakes; Judith A Aberg
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-15       Impact factor: 3.731

Review 3.  HIV protease inhibitors in pregnancy : pharmacology and clinical use.

Authors:  Nisha Andany; Mona R Loutfy
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

Review 4.  Pharmacokinetic optimization of antiretroviral therapy in pregnancy.

Authors:  Kajal Buckoreelall; Tim R Cressey; Jennifer R King
Journal:  Clin Pharmacokinet       Date:  2012-10-01       Impact factor: 5.577

5.  Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily.

Authors:  C D Zorrilla; R Wright; O O Osiyemi; S Yasin; B Baugh; K Brown; B Coate; P Verboven; J Mrus; R Falcon; T N Kakuda
Journal:  HIV Med       Date:  2013-06-03       Impact factor: 3.180

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.